Skip to main content
. Author manuscript; available in PMC: 2010 Apr 13.
Published in final edited form as: J Alzheimers Dis. 2009 Nov;18(3):691–701. doi: 10.3233/JAD-2009-1227

Table 5.

Demographics [mean (SD)] and distribution [number (%)] with clinically possible AD in community compared to clinic cohorts

Community cohorts
Clinical cohort
Number 42 46
Age at death 87.2 (SD = 6.6) 81.3 (SD = 6.3)
Education 16.9 (SD = 3.1) 14.3 (SD = 3.5)
MMSE 13.4 (SD = 8.4) 5.8 (SD = 7.5)
Pathologic diagnosis
of AD (NIA-Reagan)
24 (57.1%) 41 (89.1%)
    High 7 (16.7%) 27 (58.7%)
    Intermediate 17 (40.5%) 14 (30.4%)
Infarcts (any) 28 (66.7%) 19 (41.3%)
    Macroscopic 27 (64.3%) 14 (30.4%)
    Microscopic 16 (38.1%) 10 (21.7%)
Lewy bodies (any) 11 (26.2%) 22 (47.8%)
    Neocortical 7 (16.7%) 19 (41.3%)
One pathology (AD,
infarcts, or Lewy bodies)
21 (50%) 13 (28.3%)
Mixed pathology 17 (40.5%) 29 (63%)
FTLD or other atypical
pathology
0 1 (2.2%)